54
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1147001
FivepHusion develops Deflexifol™, aiming to optimize chemotherapy for better cancer treatment outcomes.
- John Bremner: Founder and Advisory Board
- Philip Clingan: Founder and Advisory Board
About the Company
FivepHusion is a biotechnology company focused on the development of innovative cancer treatments. It is working on Deflexifol™, a novel anti-cancer drug intended to optimize chemotherapy and improve patient treatment outcomes and quality of life. This drug aims to serve as a bioequivalent replacement for current standard of care formulations,
addressing significant limitations in treatment efficacy. Additionally, FivepHusion is involved in the development of drug-specific DRP® companion diagnostics for personalized cancer care, highlighting its commitment to advancing cancer treatment through precision medicine and tailored therapeutic approaches.
